Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Boehringer Ingelheim Pharmaceuticals, Inc.
FDA Inspection
•Boehringer Ingelheim Pharmaceuticals, Inc.•September 11, 2025

Boehringer Ingelheim Pharmaceuticals, Inc. – FDA Inspection, Sep 11, 2025

Record Details

This FDA Inspection record concerns Boehringer Ingelheim Pharmaceuticals, Inc., with an inspection on September 11, 2025, issued by the New England District Office, covering human drugs.

Company
Boehringer Ingelheim Pharmaceuticals, Inc.
Inspection Date
September 11, 2025
Product Type
Human Drugs
Office
New England District Office
Person
  • Kent A. Conforti (Company Rep)
View Company Profile

ID · 9c62d459-d5fc-4614-8d41-987968509962

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1281125
FDA center
Human Drugs
Project area
Bioresearch Monitoring: Human Drugs
Outcome
Form 483 issued, view the record

FDA Citations

1
  1. 21 CFR 312.50Ensuring compliance with plan and protocol

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Boehringer Ingelheim Pharmaceuticals, Inc.

19
DateClassificationOfficeProject area
August 25, 2026Not classifiedNew England District Office
May 2, 2024Not classifiedNew England District Office
September 22, 2023NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
December 12, 2019VAICenter for Drug Evaluation and ResearchBioresearch Monitoring
December 6, 2018VAICenter for Drug Evaluation and ResearchBioresearch Monitoring
View all 19 other inspections on the company page
Other documents for Boehringer Ingelheim Pharmaceuticals, Inc.
  • FDA Inspection 1334848 - 2026-08-25
  • FDA Inspection 1235545 - 2024-05-02
  • FDA Inspection 1219707 - 2023-09-22
  • FDA Inspection 1112627 - 2019-12-12
  • FDA Inspection 1073537 - 2018-12-06

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Boehringer Ingelheim Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.